Comparison between Accretion Nutraveda IPO and INDO SMC IPO.
Accretion Nutraveda IPO is a SME Bookbuilding IPO proposed to list at BSE SME while INDO SMC IPO is a SME Bookbuilding proposed to list at BSE SME.
| Accretion Nutraveda IPO | INDO SMC IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Sobhagya Capital Options Pvt.Ltd. | GYR Capital Advisors Pvt.Ltd. |
| Registrar | Kfin Technologies Ltd. | Kfin Technologies Ltd. |
| Market Maker | Sunflower Broking Pvt.Ltd. | Giriraj Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Accretion Nutraveda IPO is up to ₹23.53 Cr whereas the issue size of the INDO SMC IPO is up to ₹87.34 Cr. The final issue price of Accretion Nutraveda IPO is ₹129.00 per share and of INDO SMC IPO is ₹149.00 per share.
| Accretion Nutraveda IPO | INDO SMC IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹122.00 per share | ₹141.00 per share |
| Issue Price (Upper) | ₹129.00 per share | ₹149.00 per share |
| Issue Price (Final) | ₹129.00 per share | ₹149.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | 1000 shares |
| Fresh Issue Size | 18,24,000 shares | 58,62,000 shares |
| Fresh Issue Size (Amount) | up to ₹23.53 Cr | up to ₹87.34 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 18,24,000 shares | 58,62,000 shares |
| Issue Size Total (Amount) | up to ₹23.53 Cr | up to ₹87.34 Cr |
Accretion Nutraveda IPO opens on Jan 28, 2026, while INDO SMC IPO opens on Jan 13, 2026. The closing date of Accretion Nutraveda IPO and INDO SMC IPO is Jan 30, 2026, and Jan 16, 2026, respectively.
| Accretion Nutraveda IPO | INDO SMC IPO | |
|---|---|---|
| Anchor Bid Date | Jan 27, 2026 | Jan 12, 2026 |
| Issue Open | Jan 28, 2026 | Jan 13, 2026 |
| Issue Close | Jan 30, 2026 | Jan 16, 2026 |
| Basis Of Allotment (Tentative) | Feb 02, 2026 | Jan 19, 2026 |
| Initiation of Refunds (Tentative) | Feb 03, 2026 | Jan 20, 2026 |
| Credit of Share (Tentative) | Feb 03, 2026 | Jan 20, 2026 |
| Listing date (Tentative) | Feb 04, 2026 | Jan 21, 2026 |
| Anchor Lockin End date 1 | Mar 03, 2026 | Feb 15, 2026 |
| Anchor Lockin End date 2 | May 02, 2026 | Apr 16, 2026 |
Accretion Nutraveda IPO P/E ratio is 26.27, as compared to INDO SMC IPO P/E ratio of 16.1.
| Accretion Nutraveda IPO | INDO SMC IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 82.30 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.48 | 60.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 26.27 | 16.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹93.40 Cr. | ₹340.54 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 81.22 | 74.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 36.98 | 31.39 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.72 | 1.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.91 | ₹9.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 48.85 | 43.27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Accretion Nutraveda IPO Retail Individual Investors (RII) are offered 6,40,000 shares while in INDO SMC IPO retail investors are offered 6,40,000 shares. Qualified Institutional Buyers (QIB) are offered 3,64,000 shares in Accretion Nutraveda IPO and 11,72,000 shares in INDO SMC IPO.
| Accretion Nutraveda IPO | INDO SMC IPO | |
|---|---|---|
| Anchor Investor Reservation | 5,44,000 shares | 17,56,000 shares |
| Market Maker Reservation | 96,000 shares | 3,09,000 shares |
| QIB | 3,64,000 shares | 11,72,000 shares |
| NII | 2,76,000 shares | 8,82,000 shares |
| RII | 6,40,000 shares | 20,52,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 18,24,000 shares | 58,62,000 shares |
Accretion Nutraveda IPO subscribed 1.29x in total, whereas INDO SMC IPO subscribed 77.39x.
| Accretion Nutraveda IPO | INDO SMC IPO | |
|---|---|---|
| QIB (times) | 1.01x | 94.94x |
| NII (times) | 2.08x | 164.59x |
| Big NII (times) | 1.95x | 193.37x |
| Small NII (times) | 2.33x | 107.02x |
| RII (times) | 2.19x | 96.13x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.29x | 77.39x |
